These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2858651)

  • 1. HLA antigen expression in myositis.
    Isenberg DA; Rowe D; Beverley PC
    Lancet; 1985 Mar; 1(8430):703. PubMed ID: 2858651
    [No Abstract]   [Full Text] [Related]  

  • 2. The Jo-1 antibody system in myositis: relationships to clinical features and HLA.
    Arnett FC; Hirsch TJ; Bias WB; Nishikai M; Reichlin M
    J Rheumatol; 1981; 8(6):925-30. PubMed ID: 6977032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B8 in polymyositis.
    Behan WM; Behan PO; Dick HA
    N Engl J Med; 1978 Jun; 298(22):1260-1. PubMed ID: 651970
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA antigens in adult polymyositis.
    Cumming WJ; Hudgson P; Wilcox CB
    N Engl J Med; 1978 Dec; 299(24):1365. PubMed ID: 714109
    [No Abstract]   [Full Text] [Related]  

  • 5. [Is inclusion body myositis a true myositis?].
    Serratrice G
    Rev Rhum Ed Fr; 1993 Mar; 60(3):187-8. PubMed ID: 8293003
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders.
    Appleyard ST; Dunn MJ; Dubowitz V; Rose ML
    Lancet; 1985 Feb; 1(8425):361-3. PubMed ID: 2857418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis, dermatomyositis, and polymyositis: immunopathological diseases.
    Penn AS
    Adv Neurol; 1977; 17():41-61. PubMed ID: 302085
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies.
    van der Pas J; Hengstman GJ; ter Laak HJ; Borm GF; van Engelen BG
    J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):136-9. PubMed ID: 14707323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA and serum complement in polymyositis.
    Cumming WJ; Hudgson P; Lattimer D; Sussman M; Wilcox CB
    Lancet; 1977 Nov; 2(8045):978-9. PubMed ID: 72313
    [No Abstract]   [Full Text] [Related]  

  • 10. Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis.
    Badrising UA; Schreuder GM; Giphart MJ; Geleijns K; Verschuuren JJ; Wintzen AR; Maat-Schieman ML; van Doorn P; van Engelen BG; Faber CG; Hoogendijk JE; de Jager AE; Koehler PJ; de Visser M; van Duinen SG;
    Neurology; 2004 Dec; 63(12):2396-8. PubMed ID: 15623710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.
    Love LA; Leff RL; Fraser DD; Targoff IN; Dalakas M; Plotz PH; Miller FW
    Medicine (Baltimore); 1991 Nov; 70(6):360-74. PubMed ID: 1659647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G.
    Wiendl H; Behrens L; Maier S; Johnson MA; Weiss EH; Hohlfeld R
    Ann Neurol; 2000 Oct; 48(4):679-84. PubMed ID: 11026456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue disease in southeast Georgia. A community based study of immunogenetic markers and autoantibodies.
    Arnett FC; Bias WB; McLean RH; Engel M; Duvic M; Goldstein R; Freni-Titulaer L; McKinley TW; Hochberg MC
    J Rheumatol; 1990 Aug; 17(8):1029-35. PubMed ID: 1976808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies.
    Hohlfeld R; Engel AG
    Ann Neurol; 1991 May; 29(5):498-507. PubMed ID: 1830466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy.
    Rider LG; Gurley RC; Pandey JP; Garcia de la Torre I; Kalovidouris AE; O'Hanlon TP; Love LA; Hennekam RC; Baumbach LL; Neville HE; Garcia CA; Klingman J; Gibbs M; Weisman MH; Targoff IN; Miller FW
    Arthritis Rheum; 1998 Apr; 41(4):710-9. PubMed ID: 9550481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy.
    Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Weiss EH; Dichgans J; Lochmuller H; Hohlfeld R; Melms A; Weller M
    Brain; 2003 Jan; 126(Pt 1):176-85. PubMed ID: 12477705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis.
    Betteridge ZE; Gunawardena H; Chinoy H; North J; Ollier WE; Cooper RG; McHugh NJ;
    Ann Rheum Dis; 2009 Oct; 68(10):1621-5. PubMed ID: 18930994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies in myositis.
    Bernstein RM
    Baillieres Clin Neurol; 1993 Nov; 2(3):599-615. PubMed ID: 7512408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal myositis: a new HLA-DR4 0401 associated disease?
    Caunes O; Chevrel G; Miossec P
    J Rheumatol; 1999 Nov; 26(11):2502-3. PubMed ID: 10555921
    [No Abstract]   [Full Text] [Related]  

  • 20. An update on the immunogenetics of idiopathic inflammatory myopathies: major histocompatibility complex and beyond.
    Chinoy H; Lamb JA; Ollier WE; Cooper RG
    Curr Opin Rheumatol; 2009 Nov; 21(6):588-93. PubMed ID: 19730377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.